US-based medical devices maker Qfix has introduced its new ZiFix Abdominal/Thoracic Motion Control System designed to stimulate shallow breathing for the management of internal body motion caused due to respiration.
The 17th Indian Premier B2B Medical Equipment Show (Medicall) was successfully held in Chennai, the fourth largest city in India, from 28 July to 30 July 2017.
Cardinal Health has concluded the purchase of Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business from Medtronic for a total of $6.1bn.
Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.
Medication management systems provider Plexus Technology Group (TG) is set to integrate its anaesthesia information management system (AIMS) with medical imaging firm Codonics’ medication safety technology Safe Label System (SLS) for an improved anaesthesia process.
Pharma Asia 2017 Pharma Asia is a 3 day event being held from 22nd August to the 24th August 2017 at the Karachi Expo Center in Karachi, Pakistan. This event showcases products like providing investors with a definite outlook of the regional pharmaceutical industry and an opportunity to meet their prospective counterparts and business partners etc. in the Medical & Pharmaceutical industry. Echemi Pharma Forum: From August 22 to 24, Echemi will attend Pharma Asia exhibition, and will take other three Chinese companies to this exhibition. On one side, for visitors, this is a good chance for them to know suppliers and choose their needs directly. On the other side, for suppliers, this is an opportunity to show their products and let more people know their companies. During exhibition period, Echemi will hold “Pharma Forum & Procurement Conference”, which is a face-to-face meeting for suppliers and buyers. There will be ...
The 69th Annual Scientific Meeting and Clinical Lab Exposition (AACC) will be held in Orlando, USA from August 1st to August 3rd, 2017.
AstraZeneca and Merck & Co have announced a global strategic oncology collaboration to co-develop and co-commercialise the former’s Lynparza and selumetinib for multiple cancer types.
Novo Nordisk’s diabetes drug Victoza is now approved in Europe as the only GLP-1 analogue with a label including prevention of cardiovascular events.
Medtronic’s Canadian subsidiary has launched its new magnetic resonance imaging (MRI) conditional cardiac resynchronisation therapy defibrillators (CRT-Ds)
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.